Experimental antiviral drug with potential activity against RNA viruses
You can help expand this article with text translated from the corresponding article in German. (March 2021) Click [show] for important translation instructions.
View a machine-translated version of the German article.
Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
Consider adding a topic to this template: there are already 1,921 articles in the main category, and specifying|topic= will aid in categorization.
Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing German Wikipedia article at [[:de:Favipiravir]]; see its history for attribution.
You may also add the template {{Translated|de|Favipiravir}} to the talk page.
Favipiravir, sold under the brand name Avigan among others,[3] is an antiviral medication used to treat influenza in Japan.[4] It is also being studied to treat a number of other viral infections, including SARS-CoV-2.[4] Like the experimental antiviral drugs T-1105 and T-1106, it is a pyrazinecarboxamide derivative.[5]
It is being developed and manufactured by Toyama Chemical (a subsidiary of Fujifilm) and was approved for medical use in Japan in 2014.[6] In 2016, Fujifilm licensed it to Zhejiang Hisun Pharmaceutical Co.[7] It became a generic drug in 2019.[citation needed]
^Cite error: The named reference Avifavir was invoked but never defined (see the help page).
^Cite error: The named reference Areplivir was invoked but never defined (see the help page).
^"Glenmark launches Covid-19 drug FabiFlu, priced at Rs 103 per tablet". Business Standard India. Press Trust of India. 20 June 2020.
^ abDu YX, Chen XP (August 2020). "Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection". Clinical Pharmacology and Therapeutics. 108 (2): 242–247. doi:10.1002/cpt.1844. PMID 32246834.
^Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL, et al. (June 2009). "T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections". Antiviral Research. 82 (3): 95–102. doi:10.1016/j.antiviral.2009.02.198. PMC 7127082. PMID 19428599.
^Cite error: The named reference Shi2020 was invoked but never defined (see the help page).
^EJ Lane (22 June 2016). "Fujifilm in Avigan API license with Zhejiang Hisun Pharmaceuticals". Fierce Pharma. Retrieved 20 April 2020.
Favipiravir, sold under the brand name Avigan among others, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat...
"Glenmark launches Favipiravir for treatment of mild to moderate COVID-19 patients". cnbctv18.com. "Glenmark Launches COVID-19 Drug Favipiravir At Rs 103 Per...
29 July 2020, the company launched its version of the anti viral drug Favipiravir under the brand name Favivir, after getting approval from Drugs Controller...
2020 COVID-19 pandemic, one of Fujifilm Toyama Chemical drugs, i.e. favipiravir, an antiviral commercially named Avigan, is being considered as a possible...
injected intravenously, such as intravenous formulations of zanamivir; favipiravir, which is a polymerase inhibitor used against several RNA viruses; pimodivir...
also been studied in an animal model with potential benefit. Acyclovir, favipiravir, and remdesivir have been assessed as potential antivirals against Nipah...
The department was also successful in synthesizing the anti-viral drug Favipiravir for use against the SARS-CoV-2 in partnership with the company Lasa Supergenerics...
recommended is the avoidance of tick and insect bites. In mice models, Favipiravir has been shown to be beneficial both therapeutically and prophylactically...
production and marketing of areplivir, a drug developed on the basis of favipiravir molecule for the treatment of COVID-19. That same year, the Company placed...
As of 2019[update], it was found to be safe and effective for humans. Favipiravir (Avigan) is a broad-spectrum antiviral drug, used to treat influenza...
Global Information
